BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Business

  Daré Bioscience Reports Third Quarter 2023 Financial Results and Provides Company Update

  Daré Bioscience, Inc., a leader in women’s health innovation, reported financial results for the quarter ended September 30, 2023 and provided a company update.

  November 9, 2023

   · 

  17 min read
• Business

  Phathom Pharmaceuticals Reports Third Quarter 2023 Results and Recent Business Updates

  Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, today reported financial results for the third quarter of 2023 and provided updates on recent regulatory and business progress.

  November 9, 2023

   · 

  9 min read
• Business

  PMV Pharmaceuticals Reports Third Quarter 2023 Financial Results and Corporate Highlights

  PMV Pharmaceuticals, Inc. reported financial results for the third quarter ended September 30, 2023, and provided a corporate update.

  November 9, 2023

   · 

  8 min read
• Business

  Comera Life Sciences Reports Financial Results for Third Quarter 2023 and Recent Business Highlights

  Comera Life Sciences Holdings, Inc. reported financial results for the third quarter ended September 30, 2023, and provided a business update.

  November 9, 2023

   · 

  11 min read
• Business

  BioSyent Schedules Q3 and YTD 2023 Earnings Release for November 16, 2023

  BioSyent Inc. will be reporting its financial results for the three and nine months ended September 30, 2023 on Thursday, November 16, 2023 before market hours.

  November 9, 2023

   · 

  1 min read
• Business

  Immunovant Reports Financial Results and Provides Corporate Updates for the Quarter Ended September 30, 2023

  Immunovant, Inc. reported corporate updates and financial results for its fiscal second quarter ended September 30, 2023.

  November 9, 2023

   · 

  10 min read
• Business

  MiNK Therapeutics Reports Third Quarter 2023 Results

  MiNK Therapeutics, Inc. reported financial results for the third quarter 2023.

  November 9, 2023

   · 

  5 min read
• Lone Star Bio

  Nanoscope Therapeutics to Present at the 4th Annual Dry AMD Therapeutic Development Summit

  Nanoscope Therapeutics Inc. announced that Dr. Samarendra Mohanty, President and Chief Scientific Officer will participate in a panel and present at the 4th Annual Dry AMD Therapeutic Development Summit taking place from November 14-16, 2023 in Boston, Massachusetts.

  November 9, 2023

   · 

  2 min read
• Business

  Xtant Medical Announces Record Third Quarter Revenue of $25 Million

  Xtant Medical Holdings, Inc., a global medical technology company focused on surgical solutions for the treatment of spinal disorders, reported financial and operating results for the third quarter ended September 30, 2023.

  November 9, 2023

   · 

  13 min read
• Business

  Andelyn Biosciences and The Ohio State University Collaborate for Pre-clinical and GMP Manufacturing of Novel Gene Therapies

  Andelyn Biosciences, Inc., a pioneering and patient-focused cell and gene therapy Contract Development and Manufacturing Organization, is collaborating with The Ohio State University Gene Therapy Institute for the development and clinical manufacturing of novel gene therapies.

  November 9, 2023

   · 

  3 min read